Urinary PCA3 a Superior Diagnostic Biomarker for Prostate Cancer among Ghanaian Men.
Bismark Opoku MensahLinda Ahenkorah FondjoW K B A OwireduBen AduseiPublished in: Disease markers (2022)
The urinary PCA3 assay showed a better diagnostic performance compared to serum PSA and DRE. PCA3 as a stand-alone and in combination with DRE could be a suitable complimentary marker in diagnosis and management of prostate cancer.